Skip to main content

Evaluation of the effect of topical chamomile (Matricaria chamomilla L.) oleogel as pain relief in migraine without aura: a randomized, double-blind, placebo-controlled, crossover study

Neurological Sciences volume 39, pages 1345–1353 (2018)Cite this article

Abstract

Phytotherapy is a source of finding new remedies for migraine. Traditional chamomile oil (chamomile extraction in sesame oil) is a formulation in Persian medicine (PM) for pain relief in migraine. An oleogel preparation of reformulated traditional chamomile oil was prepared and then standardized based on chamazulene (as a marker in essential oil) and apigenin via gas chromatography (GC) and high-performance liquid chromatography (HPLC) methods, respectively. A crossover double-blind clinical trial was performed with 100 patients. Each patient took two tubes of drug and two tubes of placebo during the study. Visual analog scale (VAS) questionnaires were filled in by the patients and scores were given, ranging from 0 to 10 (based on the severity of pain) during 24 h. Other complications like nausea, vomiting, photophobia, and phonophobia were also monitored. There was 4.48 ± 0.01 μl/ml of chamazulene and 0.233 mg/g of apigenin in the preparation (by correcting the amount with extraction ratio). Thirty-eight patients in the drug-placebo and 34 patients in the placebo-drug groups (a total number of 72 patients as per protocol) completed the process in the randomized controlled trial (RCT). Adapted results from the questionnaires showed that pain, nausea, vomiting, photophobia, and phonophobia significantly (p < 0.001) decreased by using chamomile oleogel on the patients after 30 min. Results supported the efficacy of chamomile oleogel as a pain relief in migraine without aura.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price includes VAT (USA)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Ayatollahi SMT, Sahebi L, Borhani-Haghighi A (2009) Epidemiologic and clinical characteristics of migraine and tension-type headaches among hospitals staffs of Shiraz (Iran). Acta Med Iran 47(2):115–120

    Google Scholar 

  2. Láinez MJ, García-Casado A, Gascón F (2013) Optimal management of severe nausea and vomiting in migraine: improving patient outcomes. Patient Relat Outcome Meas 4:61–73

    Article  PubMed  PubMed Central  Google Scholar 

  3. Serafini G, Pompili M, Innamorati M, Gentile G, Borro M, Lamis DA, Lala N, Negro A, Simmaco M, Girardi P, Martelletti P (2012) Gene variants with suicidal risk in a sample of subjects with chronic migraine and affective temperamental dysregulation. Eur Rev Med Pharmacol Sci 16(10):1389–1398

    PubMed  CAS  Google Scholar 

  4. Headache Classification Committee of the International Headache Society (IHS) (2013) The international classification of headache disorders, 3rd edition (beta version). Cephalalgia 33(9):629–808

    Article  Google Scholar 

  5. Andlin-Sobocki P, Jonsson B, Wittchen HU, Olesen J (2005) Cost of disorders of the brain in Europe. Eur J Neurol 12(Suppl 1):1–27

    Article  PubMed  Google Scholar 

  6. Hoffmann J, Goadsby PJ (2014) Emerging targets in migraine. CNS Drugs 28(1):11–17

    Article  PubMed  CAS  Google Scholar 

  7. Tfelt-Hansen PC (2013) Triptans and ergot alkaloids in the acute treatment of migraine: similarities and differences. Expert Rev Neurother 13(9):961–963

    Article  PubMed  CAS  Google Scholar 

  8. Lipton RB, Serrano D, Nicholson RA, Buse DC, Runken MC, Reed ML (2013) Impact of NSAID and triptan use on developing chronic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study. Headache 53(10):1548–1563

    Article  PubMed  Google Scholar 

  9. Lipton RB, Stewart WF (1999) Acute migraine therapy: do doctors understand what patients with migraine want from therapy? Headache 39:20–26

    Article  Google Scholar 

  10. Mohagheghzadeh A, Zargaran A, Daneshamuz S (2011) Cosmetic sciences from ancient Persia. Pharmaceutical Historian 41:18–23

    PubMed  Google Scholar 

  11. Zargaran A (2014) Ancient Persian medical views on the heart and blood in the Sassanid era (224-637 AD). Int J Cardiol 172(2):307–312

    Article  PubMed  Google Scholar 

  12. Zargaran A, Zarshenas MM, Mehdizadeh A, Mohagheghzadeh A (2013) Management of tremor in medieval Persia. J Hist Neurosci 22(1):53–61

    Article  PubMed  Google Scholar 

  13. Zargaran A, Mehdizadeh A, Zarshenas MM, Mohagheghzadeh A (2012) Avicenna (980-1037 AD). J Neurol 259:389–390

    Article  PubMed  Google Scholar 

  14. Abolhassanzadeh Z, Aflaki E, Yousefi G, Mohagheghzadeh A (2015 Apr) Randomized clinical trial of peganum oil for knee osteoarthritis. J Evid Based Complement Altern Med 20(2):126–131

    Article  CAS  Google Scholar 

  15. Hamedi A, Zarshenas MM, Sohrabpour M, Zargaran A (2013) Herbal medicinal oils in traditional Persian medicine. Pharm Biol 51(9):1208–1218

    Article  PubMed  Google Scholar 

  16. Zargaran A, Borhani-Haghighi A, Faridi P, Daneshamouz S, Mohagheghzadeh A (2016) A review on the management of migraine in the Avicenna’s Canon of Medicine. Neurol Sci 37(3):471–478

    Article  PubMed  Google Scholar 

  17. Zargaran A, Borhani-Haghighi A, Faridi F, Daneshamouz S, Kordafshari G, Mohagheghzadeh A (2014) Potential effect and mechanism of action of topical Chamomile (Matricaria chamomila L.) oil on migraine headache: a medical hypothesis. Medical Hypothesis 83:566–569

    Article  CAS  Google Scholar 

  18. Zargaran A, Faridi P, Daneshamouz S, Borhani-Haghighi A, Azadi A, Hashempur MH, Mohagheghzadeh A (2016) Renovation and standardization of a historical pharmaceutical formulation from Persian medicine: chamomile oil. Trad Integ Med 1(3):108–114

    Google Scholar 

  19. Shoara R, Hashempur MH, Ashraf A, Salehi A, Dehshahri S, Habibagahi Z (2015) Efficacy and safety of topical Matricaria chamomilla L. (Chamomile) oil for knee osteoarthritis: a randomized; controlled clinical trial. Complement Ther Clin Pract 21(3):181–187

    Article  PubMed  Google Scholar 

  20. Zargaran A, Sakhteman A, Faridi P, Daneshamouz S, Akbarizadeh AR, Borhani-Haghighi A, Mohagheghzadeh A (2017) Reformulation of traditional chamomile oil, quality controls and fingerprint presentation based on cluster analysis of ATR-IR spectral data. J Evid Based Complementary Altern Med 22:707–714. https://doi.org/10.1177/2156587217710982.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  21. Zargaran A (2015) Semisolid preparation of chamomile oil and study of its effects in migraine without aura via double blind randomized clinical trial with placebo control. PhD thesis. Shiraz: Shiraz University of Medical Sciences.

  22. Adams RP (1995) Identification of essential oil components by gas chromatography/mass spectroscopy: Allured Publishing Co.

  23. McDonald S, Prenzler PD, Autolovich M, Robards K (2001) Phenolic content and antioxidant activity of olive extracts. Food Chem 73:73–84

    Article  CAS  Google Scholar 

  24. Pourmorad F, Hosseinimehr SJ, Shahabimajd N (2006) Antioxidant activity, phenol and flavonoid contents of some selected Iranian medicinal plants. Afr J Biotech 5(11):1142–1145

    CAS  Google Scholar 

  25. Bhaskaran N, Shukla S, Srivastava JK, Gupta S (2010) Chamomile: Aan anti-inflammatory agent inhibits inducible nitric oxide synthase expression by blocking RelA/p65 activity. Int J Mol Med 26(6):935–940

    PubMed  PubMed Central  CAS  Google Scholar 

  26. Ansari M, Rafiee K, Emamgholipour S, Fallah MS (2012) Migraine: molecular basis and herbal medicine. In: Advanced Topics in Neurological Disorders. Chen KS (Ed.), ISBN: 978-953-51-0303-5, INTECH, DOI: https://doi.org/10.5772/32018. Available from: http://www.intechopen.com/books/advanced-topics-in-neurological-disorders/migraine-molecular-basis-and-herbal-medicine.

  27. Olesen J (2008) The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache. Pharmacol Ther 120(2):157–171

    Article  PubMed  CAS  Google Scholar 

  28. Barbanti P, Egeo G, Aurilia C, Fofi L, Della-Morte D (2014) Drugs targeting nitric oxide synthase for migraine treatment. Expert Opin Investig Drugs 23(8):1141–1148

    Article  PubMed  CAS  Google Scholar 

  29. Srivastava JK, Pandey M, Gupta S (2009) Chamomile, a novel and selective COX-2 inhibitor with anti-inflammatory activity. Life Sci 85(19–20):663–669

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  30. Dodick D, Silberstein S (2006) Central sensitization theory of migraine: clinical implications. Headache 46(Suppl. 4):S182–S191

    Article  PubMed  Google Scholar 

  31. Drummond EM, Harbourne N, Marete E, Martyn D, Jacquier J, O'Riordan D, Gibney ER (2013) Inhibition of proinflammatory biomarkers in THP1 macrophages by polyphenols derived from chamomile, meadowsweet and willow bark. Phytother Res 27(4):588–594

    Article  PubMed  CAS  Google Scholar 

  32. Stanimirovic DB, Friedman A (2012) Pathophysiology of the neurovascular unit: disease cause or consequence? J Cereb Blood Flow Metab 32(7):1207–1221

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  33. Phitak T, Pothacharoen P, Settakorn J, Poompimol W, Caterson B, Kongtawelert P (2012) Chondroprotective and anti-inflammatory effects of sesamin. Phytochemistry 80:77–88

    Article  PubMed  CAS  Google Scholar 

  34. Nekuzad N, Ashke Torab T, Mojab F, Alavi-Majd H, Azadeh P, Ehtejab G (2012) Effect of external use of sesame oil in the prevention of chemotherapy-induced phlebitis. Iran J Pharm Res 11(4):1065–1071

    PubMed  PubMed Central  Google Scholar 

  35. Zahmatkash M, Vafaeenasab MR (2011) Comparing analgesic effects of a topical herbal mixed medicine with salicylate in patients with knee osteoarthritis. Pak J Biol Sci 14(13):715–719

    Article  PubMed  Google Scholar 

  36. Bradley MJ (2002) Food, industrial, nutraceutical, and pharmaceutical uses of sesame genetic resources. In: Janick J, Whipkey A (eds) Trends in new crops and new uses. ASHS Press, Alexandria

    Google Scholar 

  37. Borhani Haghighi A, Motazedian S, Rezaii R, Mohammadi F, Salarian L, Pourmokhtari M, Khodaei S, Vossoughi M, Miri R (2010) Cutaneous application of menthol 10% solution as an abortive treatment of migraine without aura: a randomized, double-blind, placebo-controlled, crossed-over study. Int J Clin Pract 64(4):451–456

    Article  PubMed  CAS  Google Scholar 

  38. Zhang A, Jiang T, Luo Y, Zheng Z, Shi X, Xiao Z, Fang Y (2014) Efficacy of intravenous propacetamol hydrochloride in the treatment of an acute attack of migraine. Eur J Intern Med 25(7):629–632

    Article  PubMed  CAS  Google Scholar 

  39. Turkcuer I, Serinken M, Eken C, Yilmaz A, Akdag Ö, Uyan E, Kiray C, Elicabuk H (2014) Intravenous paracetamol versus dexketoprofen in acute migraine attack in the emergency department: a randomised clinical trial. Emerg Med J 31(3):182–185

    Article  PubMed  Google Scholar 

  40. Goldstein J, Hagen M, Gold M (2014) Results of a multicenter, double-blind, randomized, parallel-group, placebo-controlled, single-dose study comparing the fixed combination of acetaminophen, acetylsalicylic acid, and caffeine with ibuprofen for acute treatment of patients with severe migraine. Cephalalgia 34(13):1070–1078

    Article  PubMed  Google Scholar 

  41. Pierce MW (2010) Transdermal delivery of sumatriptan for the treatment of acute migraine. Neurotherapeutics 7(2):159–163

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  42. Schulman EA (2012) Transdermal sumatriptan for acute treatment of migraineurs with baseline nausea. Headache 52(2):204–212

    Article  PubMed  Google Scholar 

  43. Herbal Medicines (2013) London: Pharmaceutical Press; . P. 179

  44. Gangur V, Kelly C, Navuluri L (2005) Sesame allergy: a growing food allergy of global proportions? Ann Allergy Asthma Immunol 95(1):4–11

    Article  PubMed  CAS  Google Scholar 

  45. Leduc V, Moneret-Vautrin DA, Tzen JT, Morisset M, Guerin L, Kanny G (2006) Identification of oleosins as major allergens in sesame seed allergic patients. Allergy 61(3):349–356

    Article  PubMed  CAS  Google Scholar 

  46. Oiso N, Yamadori Y, Higashimori N, Kawara S, Kawada A (2008) Allergic contact dermatitis caused by sesame oil in a topical Chinese medicine, shi-un-ko. Contact Dermatitis 58(2):109

    Article  PubMed  Google Scholar 

  47. Aberer W (2008) Contact allergy and medicinal herbs. J Dtsch Dermatol Ges 6(1):15–24

    Article  PubMed  Google Scholar 

  48. Waleczek KJ, Marques HM, Hempel B, Schmidt PC (2003) Phase solubility studies of pure (−)-alpha-bisabolol and camomile essential oil with beta-cyclodextrin. Eur J Pharm Biopharm 55(2):247–251

    Article  PubMed  CAS  Google Scholar 

  49. Bors W, Saran M (1987) Radical scavenging by flavonoid antioxidants. Free Radic Res Commun 2(4–6):289–294

    Article  PubMed  CAS  Google Scholar 

  50. Mahendra Kumar C, Singh SA (2015) Bioactive lignans from sesame (Sesamum indicum L.): evaluation of their antioxidant and antibacterial effects for food applications. J Food Sci Technol 52(5):2934–2941

    Article  PubMed  CAS  Google Scholar 

  51. Swarbrick J (2007) Encyclopedia of pharmaceutical technology. Marcel Dekker, New York, pp 3327–3329

    Google Scholar 

  52. Wu WH (2007) The contents of lignans in commercial sesame oils of Taiwan and their changes during heating. Food Chem 104(1):341–344

    Article  CAS  Google Scholar 

  53. Chen GL, Hsu WY (2001) Oral pharmaceutical preparation embedded in an oily matrix and methods of making the same. US Patent 6:306–435

    Google Scholar 

  54. Cal K (2006) How does the type of vehicle influence the in vitro skin absorption and elimination kinetics of terpenes? Arch Dermatol Res 297(7):311–315

    Article  PubMed  CAS  Google Scholar 

  55. Herman A, Herman AP (2015) Essential oils and their constituents as skin penetration enhancer for transdermal drug delivery: a review. J Pharm Pharmacol 67(4):473–485

    Article  PubMed  CAS  Google Scholar 

  56. Slayton TM, Valberg PA, Wait AD (1998) Estimating dermal transfer from PCB-contaminated porous surfaces. Chemosphere 36(14):3003–3014

    Article  PubMed  CAS  Google Scholar 

  57. Vintiloiu A, Lafleur M, Bastiat G, Leroux JC (2008) In situ-forming oleogel implant for rivastigmine delivery. Pharm Res 25(4):845–852

    Article  PubMed  CAS  Google Scholar 

  58. Wang C, Hou H, Nan K, Sailor MJ, Freeman WR, Cheng L (2014) Intravitreal controlled release of dexamethasone from engineered microparticles of porous silicon dioxide. Exp Eye Res 129:74–82

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  59. Mattern C (2014) Controlled release delivery system for nasal applications and method of treatment. US Patent App 14(/322):319

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharmaceutical Sciences Research Center, and Department of Phytopharmaceuticals (Traditional Pharmacy), School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran

    Arman Zargaran & Abdolali Mohagheghzadeh

  2. Department of Traditional Pharmacy, School of Persian Medicine, Tehran University of Medical Sciences, Tehran, Iran

    Arman Zargaran

  3. Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

    Afshin Borhani-Haghighi

  4. Department of Neurology, Shiraz University of Medical Sciences, Shiraz, Iran

    Afshin Borhani-Haghighi

  5. Department of Biostatistics, Faculty of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

    Mohammad Salehi-Marzijarani

  6. Research Office for the History of Persian Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

    Pouya Faridi & Abdolali Mohagheghzadeh

  7. Department of Pharmaceutics, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran

    Saeid Daneshamouz & Amir Azadi

  8. Department of Medicinal Chemistry, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran

    Hossein Sadeghpour & Amirhossein Sakhteman

Authors
  1. Arman Zargaran
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Afshin Borhani-Haghighi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mohammad Salehi-Marzijarani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pouya Faridi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Saeid Daneshamouz
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Amir Azadi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hossein Sadeghpour
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Amirhossein Sakhteman
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Abdolali Mohagheghzadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Abdolali Mohagheghzadeh.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zargaran, A., Borhani-Haghighi, A., Salehi-Marzijarani, M. et al. Evaluation of the effect of topical chamomile (Matricaria chamomilla L.) oleogel as pain relief in migraine without aura: a randomized, double-blind, placebo-controlled, crossover study. Neurol Sci 39, 1345–1353 (2018). https://doi.org/10.1007/s10072-018-3415-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-018-3415-1

Keywords

  • Persian medicine
  • Chamomile
  • Neurological sciences
  • Migraine